These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6106885)

  • 61. Effect of orally administered celiprolol in patients with chronic atrial fibrillation.
    Lin SK; Morganroth J; Heng M; Rubler S; Baird W; Atwood JE; Mostow N; Scarse OM; Yu P; Caruso FS
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S112-5. PubMed ID: 2427838
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Effect of LB46 (a beta-adrenergic blockader) on chronic atrial fibrillation].
    Markiewicz M
    Pol Tyg Lek; 1971 Jul; 26(27):1050-1. PubMed ID: 4398483
    [No Abstract]   [Full Text] [Related]  

  • 63. Beta-adrenoceptor blockade and anaesthesia for thyroidectomy.
    Hamilton WF; Forrest AL; Gunn A; Peden NR; Feely J
    Anaesthesia; 1984 Apr; 39(4):335-42. PubMed ID: 6143513
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Beneficial effect of nadolol on anxiety-induced disturbances of performance in musicians: a comparison with diazepam and placebo.
    James I; Savage I
    Am Heart J; 1984 Oct; 108(4 Pt 2):1150-5. PubMed ID: 6148877
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Circadian rhythm of heart rate in the rabbit: prolongation of action potential duration by sustained beta adrenoceptor blockade is not due to associated bradycardia.
    Vaughan Williams EM; Dennis PD; Garnham C
    Cardiovasc Res; 1986 Jul; 20(7):528-35. PubMed ID: 2877737
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of beta blockade on singing performance.
    Gates GA; Saegert J; Wilson N; Johnson L; Shepherd A; Hearne EM
    Ann Otol Rhinol Laryngol; 1985; 94(6 Pt 1):570-4. PubMed ID: 2866749
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Nadolol and potassium iodide in combination in the surgical treatment of thyrotoxicosis.
    Peden NR; Gunn A; Browning MC; Crooks J; Forrest AL; Hamilton WF; Isles TE
    Br J Surg; 1982 Nov; 69(11):638-40. PubMed ID: 6127134
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effectiveness of low-dose nadolol for ventricular arrhythmias.
    Morganroth J; Duchin KL
    Am J Cardiol; 1986 Aug; 58(3):273-8. PubMed ID: 3739916
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Heart rate and metabolic values in long-lasting automobile trips under beta-receptor blockade (Bunitrolol)].
    Keul J; Huber G; Lehmann M
    Med Welt; 1979 Jul; 30(28):1080-5. PubMed ID: 38374
    [No Abstract]   [Full Text] [Related]  

  • 70. Diltiazem prophylaxis in refractory migraine.
    Smith R; Schwartz A
    N Engl J Med; 1984 May; 310(20):1327-8. PubMed ID: 6144044
    [No Abstract]   [Full Text] [Related]  

  • 71. [Observations on the action of digitalis in the treatment of atrial fibrillation].
    Anghelescu F; Anghelescu L; Georgescu D; Ionescu E; Isbaşescu A
    Med Interna (Bucur); 1966 Aug; 18(8):973-7. PubMed ID: 5975333
    [No Abstract]   [Full Text] [Related]  

  • 72. Some leniency on heart rate control in atrial fibrillation.
    Harv Heart Lett; 2010 Jun; 20(10):6. PubMed ID: 20589957
    [No Abstract]   [Full Text] [Related]  

  • 73. Pharmacological electrical remodelling in human atria induced by chronic beta-blockade.
    Valenzuela C
    Cardiovasc Res; 2003 Jun; 58(3):498-500. PubMed ID: 12798421
    [No Abstract]   [Full Text] [Related]  

  • 74. Nadolol binding to human serum proteins.
    Patel L; Johnson A; Turner P
    J Pharm Pharmacol; 1984 Jun; 36(6):414-5. PubMed ID: 6146679
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hemodynamic instability following intentional nadolol overdose.
    Ehgartner GR; Zelinka MA
    Arch Intern Med; 1988 Apr; 148(4):801-2. PubMed ID: 3355299
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Acute organic brain syndrome from nadolol therapy.
    Wilbur R; Kulik FA; Brecht TC
    Arch Intern Med; 1981 Nov; 141(12):1723-4. PubMed ID: 6118108
    [No Abstract]   [Full Text] [Related]  

  • 77. Intestinal absorption of a beta-adrenergic blocking agent nadolol. I. Comparison of absorption behavior of nadolol with those of other beta-blocking agents in rats.
    Yamaguchi T; Ikeda C; Sekine Y
    Chem Pharm Bull (Tokyo); 1986 Aug; 34(8):3362-9. PubMed ID: 2878735
    [No Abstract]   [Full Text] [Related]  

  • 78. [Lowering the heart rate in tachycardiac atrial fibrillation by beta receptor blockade].
    Horn HG; Neuss H; Schlepper M; Mitrovic V; Stämmler G
    Med Klin; 1980 Sep; 75(20):721-5. PubMed ID: 6106885
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Antiarrhythmic activity of esmolol (ASL-8052)--a novel ultra-short acting beta-adrenoreceptor blocking agent.
    Klein G; Wirtzfeld A; Alt E; Steck J; Saunders R; Hulse J; Kartzinel R; Lee R; Laddu AR
    Int J Clin Pharmacol Ther Toxicol; 1984 Feb; 22(2):112-7. PubMed ID: 6142005
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of nadolol on the spontaneous and exercise-provoked heart rate of patients with chronic atrial fibrillation receiving stable dosages of digoxin.
    DiBianco R; Morganroth J; Freitag JA; Ronan JA; Lindgren KM; Donohue DJ; Larca LJ; Chadda KD; Olukotun AY
    Am Heart J; 1984 Oct; 108(4 Pt 2):1121-7. PubMed ID: 6148872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.